Emtricitabine for Naive Child Chinese Chronic Hepatitis B Patients
Status:
Unknown status
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
This study evaluates generic emtricitabine(FTC) in Chinese naive children chronic hepatitis B
patients. Single group of child patients were enrolled, which include HBeAg positive and
negative Chronic hepatitis B(CHB)group.
Phase:
Phase 4
Details
Lead Sponsor:
Asian-Pacific Alliance of Liver Disease, Beijing
Collaborators:
Beijing Ditan Hospital Hebei Medical University Pharmaceutical Factory National Health and Family Planning Commission, P.R.China